Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 174,927 | 72,307 | 22,954 | 45,006 | 19,522 |
| Marketable Securities | 581,386 | 193,883 | 147,355 | 166,864 | 321,586 |
| Receivables | 61,047 | 42,449 | 39,312 | 35,038 | 91,646 |
| Inventories | 9,126 | 14,114 | 23,969 | 13,294 | 27,326 |
| Other current assets | 5,785 | 8,806 | 2,657 | 2,267 | 4,671 |
| TOTAL | $832,271 | $331,559 | $237,429 | $263,601 | $464,751 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 15,607 | 12,482 | 13,191 |
| Investments And Advances | 167,951 | 10,908 | 49,321 | 3,000 | 0 |
| Intangibles | 326,979 | 371,898 | 402,976 | 458,310 | 492,474 |
| Other Non-Current Assets | 233,436 | 227,409 | 81,883 | 25,275 | 327,174 |
| TOTAL | $728,366 | $610,215 | $549,787 | $499,067 | $832,839 |
| Total Assets | $1,560,637 | $941,774 | $787,216 | $762,668 | $1,297,590 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 76,695 | 0 |
| Accounts payable and accrued liabilities | 3,238 | 5,233 | 2,427 | 5,307 | 8,403 |
| Accrued Expenses | 31,453 | 27,906 | 12,467 | 15,681 | 17,579 |
| Other current liabilities | 422 | 1,508 | 256 | 57 | 13,616 |
| TOTAL | $37,447 | $37,112 | $16,782 | $98,810 | $41,665 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 1,222 | 355 | 654 |
| Other Non-Current Liabilities | 469,959 | 39,453 | 36,455 | 35,714 | 403,910 |
| TOTAL | $505,978 | $74,223 | $69,521 | $66,373 | $434,766 |
| Total Liabilities | $543,425 | $111,335 | $86,303 | $165,183 | $476,431 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,941 | 19,255 | 17,705 | 17,077 | 16,853 |
| Common Shares | 20 | 20 | 18 | 17 | 17 |
| Retained earnings | 608,088 | 498,984 | 503,016 | 450,862 | 449,090 |
| Other shareholders' equity | 8,455 | -5,942 | -817 | -984 | -917 |
| TOTAL | $1,017,212 | $830,439 | $700,913 | $597,485 | $821,159 |
| Total Liabilities And Equity | $1,560,637 | $941,774 | $787,216 | $762,668 | $1,297,590 |